This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
FDA Links Hydroxycut Weight Loss Supplements to Liver Damage
Manufacturer Recalls More Than a Dozen Products
By News Staff
Katz said several additional cases of liver failure resolved when patients stopped taking Hydroxycut.
In conjunction with the FDA warning, Iovate Health Sciences Inc., of Oakville, Ontario, and Iovate Health Sciences USA Inc. of Blasdell, N.Y., makers of Hydroxycut products, announced a recall of more than a dozen of the weight loss products from the market.
"Although the liver damage appears to be relatively rare, FDA contends the consumer should not be exposed to unnecessary risk," Katz said. "FDA continues to investigate the potential relationship between the use of Hydroxycut dietary supplements and liver injury and other potentially serious side effects."
Katz said the FDA has not determined which Hydroxycut ingredient dosages may be associated with the risk of developing liver disease. She said there were overlapping ingredients in the recalled products, but no single ingredient was common to all the products.
The FDA is advising consumers to discontinue use of Hydroxycut weight loss products and to consult a physician if they are experiencing any symptoms of liver injury, including jaundice, brown urine, nausea, vomiting, light colored stools, unusual tiredness, weakness, stomach or abdominal pain, unexplained itching, and loss of appetite. Other health problems related to the use of Hydroxycut products reported to the FDA include seizures, cardiovascular disorders and rhabdomyolysis.
Physicians or patients should report any adverse events associated with the use of dietary supplements to the FDA's MedWatch Program online or by calling (800) 332-1088.
Hydroxycut's Cleanse and Hoodia products are not affected by the recall.
AAFP Invites Members to Sign Up for Health Care Notification Network
Online System Delivers Safety Alerts Faster Than Standard Mail, Fax
(4/22/2009)
FDA Requires Boxed Warning for Metoclopramide Products
Chronic Use Linked to Tardive Dyskinesia
(3/11/2009)
FDA Issues Health Advisory for Raptiva
Psoriasis Drug Associated With Three Deaths
(2/24/2009)
More From AAFP
American Family Physician
Few Data on Dietary Supplements for Sustained Weight Loss
(Sept. 15, 2004)
This was successfully posted to your pofile.
This box will close automatically in a few seconds. Close this window
We don't have an e-mail address on file for you. To use AAFP Connection, you must have an e-mail address in our records. Click Here
Study: PPI Does Not Routinely Improve Asthma Control
Recalled Oral Contraceptives Pose Pregnancy Risk
CDC to Fund 2D Vaccine Barcoding Pilot
2012 Immunization Schedules Reflect Multiple Changes
Study: Cognitive Decline Detected in Middle-aged Adults
CDC Toolkit Can Help Clinicians Fight Norovirus Infection
Patient-Centered Care Linked to Lower Mortality
Study: Inappropriate Cancer Screenings Continue
Novartis Manufacturing Plant Closes After Drug Mix-ups
FDA Announces Classwide REMS for TIRF Medications
New Infants' Acetaminophen Products Hit Store Shelves
Avoid Environmental Factors Linked to Breast Cancer
Risk for Thrombosis Prompts REMS for Rivaroxaban
Common Drugs Implicated in Most Emergency Hospitalizations
CDC Launches Campaign for Child Medication Safety
HHS Blocks Expanded OTC Access to Plan B
Push Is On to Vaccinate Pregnant, Postpartum Women
FDA Committee Votes to Broaden PCV13 Indication
AAFP Foundation Program Aims to Fight Chronic Disease
NIAAA Alcohol Screening Guide Targets Teens
Walgreens, AAFP Launch Flu Vaccine Pilot in Five States
Helping Patients Quit Smoking Starts With a Question
Trilipix Efficacy in Question, Says FDA
USPSTF Addresses Skin Cancer, Obesity, Cervical Cancer Screening
AAFP Endorses ACP Guideline on ED
ACIP Recommends Expanded HPV, Hepatitis B Vaccination
Bacterial Contamination Spurs Nasal Spray Recall
CDC Renews Call for PCV13 Vaccination
USPSTF Recommends Against PSA Screening
AAFP Supports HHS' Million Hearts Initiative
FDA Phases Out Primatene Mist Inhalers
AHRQ Guides Explain Benefits, Risks of GERD Treatments
Office Champions Project Nets Smoking Cessation Gains
Multiple Lots of Oral Contraceptives Recalled
New Vaccine Review Finds Few Adverse Events
HPV Vaccination Rates Still Lag, Says CDC
Renal Injury Prompts Reclast Label Changes
High-dose Citalopram Linked to Abnormal Heart Rhythms
AHRQ Sleep Apnea Guides Review Diagnosis, Management
Board Chair Spotlights Breadth of Family Medicine Training
USPSTF Softens Stance on Bladder Cancer Screening
HHS Expands Coverage for Women's Preventive Services
Teledermatology Project Aids Underserved Patients
